AstraZeneca's failed cancer drug gets new lease on life thanks to positive kidney...

[cafead]

via More than a decade after AstraZeneca appeared to give up hope of using zibotentan to treat prostate cancer, the endothelin receptor antagonist has received a new lease on life as a combo treatment for chronic kidney disease (CKD) patients.

article source